French National Agency for Research on AIDS and Viral Hepatitis Clinical Trials
Sponsors / French National Agency for Research on AIDS and Viral Hepatitis
The ClinicalTrials.gov registry records 71 trials led by French National Agency for Research on AIDS and Viral Hepatitis. Across the portfolio, 0 are in recruitment, 0 are active non-recruiting, and 49 have reached completion. 18 trials have been terminated or withdrawn. The most common reasons cited for termination include slow or insufficient recruitment, efficacy or futility findings. Across the portfolio, planned enrollment totals 62,857 participants. Data on this page mirrors the ClinicalTrials.gov registry as of the most recent refresh.
71
Total Trials
0
Recruiting
0
Other Active
49
Completed
18
Terminated / Withdrawn
62,857
Total Enrollment
Termination reasons: Other78% · Recruitment6% · Efficacy6% · Safety6% · Regulatory6%
Recent Terminations
- Chronic Hepatitis C"Suspension of use of medicine containing Pioglitazone by French regulatory agency"
- HBe Negative Chronic Hepatitis B"safety aspects"
- HIV Infections"only one patient enrolled"
- HIV Infections
- Giant Lymph Node Hyperplasia
- HIV Infections
- HIV Infections
- HIV Infections
- AIDS Related Lymphoma
- NCT00158535 Phase PHASE2HIV Infections